Application no. and date | 92402630.5 (espacenet) (Federated) (European Patent Register), 19920925 | Patent/reg. no. and date | DK/EP 0534859, 19941117 | Publication date | 19930331 | Priority no. and date | FR 9111894, 19910927 | EP pub. no. and date |
EP 0534859 19930331 | Effective date | | Applicant/owner | LES LABORATOIRES SERVIER, 22, rue Garnier
92200 Neuilly sur Seine, FR | Applicant ref. no. | 64821 | Inventor | Peglion, Jean-Louis, 5 Allee des Begonias, F-78110 Le Vesinet , FR, Vilaine, Jean-Paul, 21 rue des Vallees, F-92290 Chatenay Malabry , FR, Vian, Joel, 12 Avenue Sainte Marie, F-92370 Chaville , FR, Villeneuve, Nicole, 135 rue Danton Bat A1, F-92500 Rueil Malmaison , FR, Janiak, Philip, 11 rue A. Antonini, F-92110 Clichy , FR, Bidouard, Jean-Pierre, 5 Residence Croix Blanche, F-92380 Chilly Mazarin , FR | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/55, C07D 405/12, C07D 491/056, C07D 223/16 | Title | 3-Benzazepin-2-oner, som er substituerede med en benzocyklobutyl- eller indanylalkylaminoalkylgruppe, og som er anvendelige til behandling af cardiovaskulære sygdomme | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2006 00007 | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|